A Phase 3 Multi-center, Long-term Extension Study Investigating The Efficacy And Safety Of Pf-04965842, With Or Without Topical Medications, Administered To Subjects Aged 12 Years And Older With Moderate To Severe Atopic Dermatitis
Principal Investigator
Vincent C. HoOverview
Study Start/End
Oct 11, 2018 to Jul 4, 2021Locations
Vancouver General HospitalPhone
604-875-5296Purpose of Study
The purpose of this study is to learn about the long-term safety and effectiveness of the study drug, PF-04965842 in participants who previously participated in PF-04965842 AD Phase 3 trials.
Eligibility
Visit ClinicalTrials.gov for more information.
Disclaimer
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.